HRP921237A2 - Protein c containing pharmaceutical preparation - Google Patents

Protein c containing pharmaceutical preparation

Info

Publication number
HRP921237A2
HRP921237A2 HR921237A HRP921237A HRP921237A2 HR P921237 A2 HRP921237 A2 HR P921237A2 HR 921237 A HR921237 A HR 921237A HR P921237 A HRP921237 A HR P921237A HR P921237 A2 HRP921237 A2 HR P921237A2
Authority
HR
Croatia
Prior art keywords
protein
pharmaceutical preparation
containing pharmaceutical
compsn
prepare
Prior art date
Application number
HR921237A
Inventor
Johann Eibl
Ludwig Pichler
Hans-Peter Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of HRP921237A2 publication Critical patent/HRP921237A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The use of opt. activated protein C (I) to prepare a compsn. for normalising increased vascular permeabilty and to inhibit permeability defects of the vascular wall is new. Also new is the use of (I) to prepare a compsn. for stimulating the beta-adrenergic receptors.
HR921237A 1990-08-16 1992-11-12 Protein c containing pharmaceutical preparation HRP921237A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0169790A AT402260B (en) 1990-08-16 1990-08-16 PROTEIN C-CONTAINING PHARMACEUTICAL PREPARATION
EP91890012A EP0471660B1 (en) 1990-08-16 1991-01-28 Protein C for treating pain
YU77591A YU77591A (en) 1990-08-16 1991-04-29 PROCEDURE FOR OBTAINING A PHARMACEUTICAL PRODUCT CONTAINING PROTEIN C

Publications (1)

Publication Number Publication Date
HRP921237A2 true HRP921237A2 (en) 1995-10-31

Family

ID=3519039

Family Applications (1)

Application Number Title Priority Date Filing Date
HR921237A HRP921237A2 (en) 1990-08-16 1992-11-12 Protein c containing pharmaceutical preparation

Country Status (12)

Country Link
EP (3) EP0533209B1 (en)
JP (1) JP2530770B2 (en)
AT (6) AT402260B (en)
CA (1) CA2041380C (en)
CZ (1) CZ280004B6 (en)
DE (3) DE59108638D1 (en)
DK (3) DK0533210T3 (en)
ES (3) ES2102435T3 (en)
HR (1) HRP921237A2 (en)
HU (1) HUT60147A (en)
RU (1) RU2066550C1 (en)
YU (1) YU77591A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
AT397615B (en) * 1991-05-14 1994-05-25 Immuno Ag MEDICINAL PRODUCT PROTEIN C
DE4320294A1 (en) * 1993-06-18 1994-12-22 Immuno Ag Use of human protein C to prevent and treat platelet deposits
DE19608218A1 (en) * 1995-03-21 1996-09-26 Immuno Ag Agent for subcutaneous administration of protein C.
EP0733371B1 (en) * 1995-03-21 2002-06-19 Baxter Aktiengesellschaft Agent for the subcutaneous application of protein C
US20080293631A1 (en) * 2005-01-07 2008-11-27 Christopher John Jackson Treatment for Autoimmune and Inflammatory Conditions
JP6273272B2 (en) * 2012-07-04 2018-01-31 ジージー バイオテック エルエルシー Treatment of inflammatory skin disorders
ES2890623T3 (en) 2014-04-16 2022-01-20 Zz Biotech Llc Use of APC analog for wound healing
DK3137102T3 (en) 2014-04-16 2021-10-11 Zz Biotech Llc APC FOR USE FOR THE TREATMENT OF ABNORMAL CUTANE FORMATION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2739050B2 (en) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 Anticoagulant
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock

Also Published As

Publication number Publication date
CA2041380A1 (en) 1992-02-17
EP0533210A1 (en) 1993-03-24
HU911348D0 (en) 1991-10-28
EP0471660B1 (en) 1995-08-23
CA2041380C (en) 1997-10-07
DE59108697D1 (en) 1997-06-05
ES2103861T3 (en) 1997-10-01
JPH04230633A (en) 1992-08-19
ATA20492A (en) 1997-10-15
EP0533209A1 (en) 1993-03-24
EP0471660A2 (en) 1992-02-19
DE59108638D1 (en) 1997-04-30
EP0533210B1 (en) 1997-05-02
RU2066550C1 (en) 1996-09-20
HUT60147A (en) 1992-08-28
AT403763B (en) 1998-05-25
DK0533210T3 (en) 1997-11-03
ATE150649T1 (en) 1997-04-15
ES2102435T3 (en) 1997-08-01
AT402260B (en) 1997-03-25
DK0533209T3 (en) 1997-09-22
ES2080289T3 (en) 1996-02-01
EP0471660A3 (en) 1992-04-15
CZ280004B6 (en) 1995-09-13
YU77591A (en) 1995-10-24
DE59106292D1 (en) 1995-09-28
ATE152354T1 (en) 1997-05-15
EP0533209B1 (en) 1997-03-26
ATA20392A (en) 1997-07-15
ATA169790A (en) 1996-08-15
JP2530770B2 (en) 1996-09-04
CS121391A3 (en) 1992-02-19
ATE126699T1 (en) 1995-09-15
DK0471660T3 (en) 1995-12-18
AT403439B (en) 1998-02-25

Similar Documents

Publication Publication Date Title
LV10434A (en) Derivatives of 3-Amidopyrazole Depletion and Pharmaceutical Composition
GR871212B (en) Therapeutic use of serotonin antagonist
EP0295721A3 (en) Promotion of healing of meniscal tissue
EP0338978A3 (en) Taste masking of thymol
ZA829408B (en) Use of peptides as medicament
EP0471660A3 (en) Pharmaceutical composition containing protein c
HUT48904A (en) Process for production of derivatives of 2-substituated adenosin and medical preparatives containing these substances
PT73061B (en) Process for the preparation of new derivatives of taurina and its pharmaceutical use
DE3272925D1 (en) Esters of aryloxypropanolamine derivatives and use as beta-adrenergic blocking agents
ZA883744B (en) Promotion of healing of meniscal tissue
ZA919769B (en) Oral administration of alpha intereron to treat lung malignancies
IT8468196A0 (en) OSMOTIC DEVICE AND PROCEDURE FOR DELIVERY OF A BENEFICIAL AGENT PARTICULARLY A DRUG TO A USE ENVIRONMENT
GB8810373D0 (en) Composition for treatment of cine film materials
EP0417298A4 (en) Detection of human tissue factor activator
IE870196L (en) Device for discharge of atomized medicament for inhalation¹air
HUT55677A (en) Hose of combined structure
PH24690A (en) 8 alpha(-acylaminoergoline, pharmaceutical composition containing said compound and method of use thereof
CS942287A1 (en) Tester of high-pressure sodium vapour lamps' thyristor starters
GB8802392D0 (en) Preparation of n-heptyl-4-(2 2 -dimethyl-propyl)-benzylamine
ZA893146B (en) Therapeutic use of serotonin antagonists
SE8700939D0 (en) PROCEDURE FOR THE PREPARATION OF THE PRESSURE BODY AND APPARATUS FOR IMPLEMENTATION OF THE PROCEDURE
DK552588D0 (en) NEW USE OF CLASS OF COMPOUNDS FOR THE PREPARATION OF A MEDICINE FOR THE DIAGNOSIS AND TREATMENT OF ERECTILE DYSFUNCTION
EG18218A (en) Process for the preparation of cellulose film,cellulose film produce thereby artificial skin graft and its use
IL82057A0 (en) Antigenic analogues of platelet activating factor
SE9202013D0 (en) SET FOR PREPARATION OF SOLUTION FOR MEDICAL USE

Legal Events

Date Code Title Description
A1OB Publication of a patent application
OBST Application withdrawn